Referências
Principais artigos
Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024 Jan 2;149(1):e1-e156.Texto completo Resumo
Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2016 Apr 5;133(14):e506-74.Texto completo Resumo
Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2018 Sep 25;138(13):e272-391.Texto completo Resumo
National Institute for Health and Care Excellence. Atrial fibrillation: diagnosis and management. Jun 2021 [internet publication].Texto completo
Artigos de referência
1. Zimetbaum P, Josephson ME. Evaluation of patients with palpitations. N Engl J Med. 1998 May 7;338(19):1369-73 Resumo
2. Mellor GJ, Behr ER. Cardiac channelopathies: diagnosis and contemporary management. Heart. 2021 Jun 11;107(13):1092-9.
3. Wilken J. Evidence-based recommendations for the evaluation of palpitations in the primary care setting. Med Clin North Am. 2016 Sep;100(5):981-9. Resumo
4. Mayou R, Bryant B, Forfar C, et al. Non-cardiac chest pain and benign palpitations in the cardiac clinic. Br Heart J. 1994 Dec;72(6):548-53.Texto completo Resumo
5. Jonsbu E, Dammen T, Morken G, et al. Patients with noncardiac chest pain and benign palpitations referred for cardiac outpatient investigation: a 6-month follow-up. Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):406-12. Resumo
6. Raviele A, Giada F, Bergfeldt L, et al. Management of patients with palpitations: a position paper from the European Heart Rhythm Association. Europace. 2011 Jul;13(7):920-34.Texto completo Resumo
7. Barsky AJ, Cleary PD, Coeytaux RR, et al. Psychiatric disorders in medical outpatients complaining of palpitations. J Gen Intern Med. 1994 Jun;9(6):306-13. Resumo
8. Gillespie HS, Lin CC, Prutkin JM. Arrhythmias in structural heart disease. Curr Cardiol Rep. 2014 Aug;16(8):510. Resumo
9. Gale CP, Camm AJ. Assessment of palpitations. BMJ. 2016 Jan 6;352:h5649.
10. Barsky AJ, Cleary PD, Sarnie MK, et al. Panic disorder, palpitations, and the awareness of cardiac activity. J Nerv Ment Dis. 1994 Feb;182(2):63-71. Resumo
11. Barsky AJ, Cleary PD, Coeytaux RR, et al. The clinical course of palpitations in medical outpatients. Arch Intern Med. 1995 Sep 11;155(16):1782-8. Resumo
12. Weber BE, Kapoor WN. Evaluation and outcomes of patients with palpitations. Am J Med. 1996 Feb;100(2):138-48. Resumo
13. Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024 Jan 2;149(1):e1-e156.Texto completo Resumo
14. Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC guidelines for the management of patients with supraventricular tachycardia The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J. 2020 Feb 1;41(5):655-720.Texto completo
15. Riley AB, Manning WJ. Atrial fibrillation: an epidemic in the elderly. Expert Rev Cardiovasc Ther. 2011 Aug;9(8):1081-90. Resumo
16. Samim D, Choffat D, Vollenweider P, et al. Prevalence of atrial fibrillation : the Swiss population-based CoLaus|PsyCoLaus study. Herz. 2023 Feb;48(1):48-54.Texto completo Resumo
17. Go AS. The epidemiology of atrial fibrillation in elderly persons: the tip of the iceberg. Am J Geriatr Cardiol. 2005 Mar-Apr;14(2):56-61. Resumo
18. Marott JL, Skielboe AK, Dixen U, et al. Increasing population height and risk of incident atrial fibrillation: the Copenhagen City Heart Study. Eur Heart J. 2018 Dec 1;39(45):4012-9.Texto completo Resumo
19. Crump C, Sundquist J, Winkleby MA, et al. Height, weight, and aerobic fitness level in relation to the risk of atrial fibrillation. Am J Epidemiol. 2018 Mar 1;187(3):417-26.Texto completo Resumo
20. Turagam MK, Velagapudi P, Kocheril AG. Atrial fibrillation in athletes. Am J Cardiol. 2012 Jan 15;109(2):296-302. Resumo
21. Parisi EJ, Chung EH. Palpitations in athletes: diagnosis, workup and treatment. Heart. 2023 Aug 10 [Epub ahead of print]. Resumo
22. Goyal R, Zivin A, Souza J, et al. Comparison of the ages of tachycardia onset in patients with atrioventricular nodal reentrant tachycardia and accessory pathway-mediated tachycardia. Am Heart J. 1996 Oct;132(4):765-7. Resumo
23. Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2016 Apr 5;133(14):e506-74.Texto completo Resumo
24. Lu CW, Wu MH, Chen HC, et al. Epidemiological profile of Wolff-Parkinson-White syndrome in a general population younger than 50 years of age in an era of radiofrequency catheter ablation. Int J Cardiol. 2014 Jul 1;174(3):530-4. Resumo
25. Wolfe RR, Driscoll DJ, Gersony WM, et al. Arrhythmias in patients with valvar aortic stenosis, valvar pulmonary stenosis, and ventricular septal defect: results of 24-hour ECG monitoring. Circulation. 1993 Feb;87(2 Suppl):I89-101. Resumo
26. Pedersen OD, Bagger H, Køber L, et al. Impact of congestive heart failure and left ventricular systolic function on the prognostic significance of atrial fibrillation and atrial flutter following acute myocardial infarction. Int J Cardiol. 2005 Apr 8;100(1):65-71. Resumo
27. Diamant MJ, Andrade JG, Virani SA, et al. Heart failure and atrial flutter: a systematic review of current knowledge and practices. ESC Heart Fail. 2021 Dec;8(6):4484-96.Texto completo Resumo
28. Ebert M, Richter S, Dinov B, et al. Evaluation and management of ventricular tachycardia in patients with dilated cardiomyopathy. Heart Rhythm. 2019 Apr;16(4):624-31. Resumo
29. Lukas Laws J, Lancaster MC, Ben Shoemaker M, et al. Arrhythmias as presentation of genetic cardiomyopathy. Circ Res. 2022 May 27;130(11):1698-722.Texto completo Resumo
30. Ommen SR, Mital S, Burke MA, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol. 2020 Dec 22;76(25):3022-55.Texto completo Resumo
31. Sen-Chowdhry S, Lowe MD, Sporton SC, et al. Arrhythmogenic right ventricular cardiomyopathy: Clinical presentation, diagnosis, and management. Am J Med. 2004 Nov 1;117(9):685-95. Resumo
32. Haugaa KH, Haland TF, Leren IS, et al. Arrhythmogenic right ventricular cardiomyopathy, clinical manifestations, and diagnosis. Europace. 2016 Jul;18(7):965-72.Texto completo Resumo
33. Josephson ME, Wellens HJ. Differential diagnosis of supraventricular tachycardia. Cardiol Clin. 1990 Aug;8(3):411-42. Resumo
34. La Vecchia L, Ometto R, Centofante P, et al. Arrhythmic profile, ventricular function, and histomorphometric findings in patients with idiopathic ventricular tachycardia and mitral valve prolapse: clinical and prognostic evaluation. Clin Cardiol. 1998 Oct;21(10):731-5. Resumo
35. Hodzic E. Assessment of rhythm disorders in classical and nonclassical mitral valve prolapse. Med Arch. 2018 Feb;72(1):9-12.Texto completo Resumo
36. Kubala M, Essayagh B, Michelena HI, et al. Arrhythmic mitral valve prolapse in 2023: evidence-based update. Front Cardiovasc Med. 2023 Apr 18:10:1130174.Texto completo Resumo
37. Possner M, Gensini FJ, Mauchley DC, et al. Ebstein's anomaly of the tricuspid valve: an overview of pathology and management. Curr Cardiol Rep. 2020 Oct 9;22(12):157. Resumo
38. Gatzoulis MA, Balaji S, Webber SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000 Sep 16;356(9234):975-81. Resumo
39. Moe TG, Abrich VA, Rhee EK. Atrial fibrillation in patients with congenital heart disease. J Atr Fibrillation. 2017 Jun 30;10(1):1612.Texto completo Resumo
40. Imazio M, Lazaros G, Picardi E, et al. Incidence and prognostic significance of new onset atrial fibrillation/flutter in acute pericarditis. Heart. 2015 Sep;101(18):1463-7. Resumo
41. Hassanabad AF, Deniset JF, Fedak PWM. Pericardial inflammatory mediators that can drive postoperative atrial fibrillation in cardiac surgery patients. Can J Cardiol. 2023 Aug;39(8):1090-102. Resumo
42. Neumann HPH, Young WF Jr, Eng C. Pheochromocytoma and paraganglioma. N Engl J Med. 2019 Aug 8;381(6):552-65. Resumo
43. Csengeri D, Sprünker NA, Di Castelnuovo A, et al. Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes. Eur Heart J. 2021 Mar 21;42(12):1170-7.Texto completo Resumo
44. Tisdale JE, Chung MK, Campbell KB, et al. Drug-induced arrhythmias: a scientific statement from the American Heart Association. Circulation. 2020 Oct 13;142(15):e214-33.Texto completo Resumo
45. Medicines and Healthcare products Regulatory Agency. Omega-3-acid ethyl ester medicines (Omacor/Teromeg 1000mg capsules): dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors. Jan 2024 [internet publication].Texto completo
46. Lombardi M, Carbone S, Del Buono MG, et al. Omega-3 fatty acids supplementation and risk of atrial fibrillation: an updated meta-analysis of randomized controlled trials. Eur Heart J Cardiovasc Pharmacother. 2021 Jul 23;7(4):e69-70.Texto completo
47. Gencer B, Djousse L, Al-Ramady OT, et al. Effect of long-term marine ɷ-3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes: a systematic review and meta-analysis. Circulation. 2021 Dec 21;144(25):1981-90.Texto completo Resumo
48. Kim EJ, Hoffmann TJ, Nah G, et al. Coffee consumption and incident tachyarrhythmias: reported behavior, mendelian randomization, and their interactions. JAMA Intern Med. 2021 Sep 1;181(9):1185-93.Texto completo Resumo
49. Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2018 Sep 25;138(13):e272-391.Texto completo Resumo
50. Varma N, Josephson ME. Therapy of "idiopathic" ventricular tachycardia. J Cardiovasc Electrophysiol. 1997 Jan;8(1):104-16. Resumo
51. Coumel P. Clinical approach to paroxysmal atrial fibrillation. Clin Cardiol. 1990 Mar;13(3):209-12. Resumo
52. Vikman S, Lindgren K, Mäkikallio TH, et al. Heart rate turbulence after atrial premature beats before spontaneous onset of atrial fibrillation. J Am Coll Cardiol. 2005 Jan 18;45(2):278-84. Resumo
53. Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation. 2002 Jun 11;105(23):2753-9. Resumo
54. Mehra R, Benjamin EJ, Shahar E, et al. Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med. 2006 Apr 15;173(8):910-6. Resumo
55. Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001 Jan 2;103(1):89-95.Texto completo Resumo
56. Stimpel M, Wambach G. [Plasma levels of atrial natriuretic peptide (ANP) in patients with paroxysmal supraventricular tachycardia and concomitant polyuria (urina spastica)]. [in ger]. Z Kardiol. 1988;77 Suppl 2:124-9. Resumo
57. Oliver JR, Twidale N, Lakin C, et al. Plasma atrial natriuretic polypeptide concentrations during and after reversion of paroxysmal supraventricular tachycardias. Br Heart J. 1988 Apr;59(4):458-62. Resumo
58. Brugada P, Gursoy S, Brugada J, et al. Investigation of palpitations. Lancet. 1993 May 15;341(8855):1254-8. Resumo
59. Thavendiranathan P, Bagai A, Khoo C, et al. Does this patient with palpitations have a cardiac arrhythmia? JAMA. 2009 Nov 18;302(19):2135-43. Resumo
60. Hoefman E, Boer KR, van Weert HC, et al. Continuous event recorders did not affect anxiety or quality of life in patients with palpitations. J Clin Epidemiol. 2007 Oct;60(10):1060-6. Resumo
61. Goldberger JJ, Cain ME, Hohnloser SH, et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Circulation. 2008 Sep 30;118(14):1497-1518.Texto completo Resumo
62. National Institute for Health and Care Excellence. Atrial fibrillation: diagnosis and management. Jun 2021 [internet publication].Texto completo
63. Agency for Healthcare Research and Quality. Remote cardiac monitoring. December 2007 [internet publication].Texto completo
64. Kinlay S, Leitch JW, Neil A, et al. Cardiac event recorders yield more diagnoses and are more cost-effective than 48-hour Holter monitoring in patients with palpitations: a controlled clinical trial. Ann Intern Med. 1996 Jan 1;124(1 Pt 1):16-20. Resumo
65. Fogel RI, Evans JJ, Prystowsky EN. Utility and cost of event recorders in the diagnosis of palpitations, presyncope, and syncope. Am J Cardiol. 1997 Jan 15;79(2):207-8. Resumo
66. Zimetbaum PJ, Kim KY, Josephson ME, et al. Diagnostic yield and optimal duration of continuous-loop event monitoring for the diagnosis of palpitations: a cost-effectiveness analysis. Ann Intern Med. 1998 Jun 1;128(11):890-5. Resumo
67. Rothman SA, Laughlin JC, Seltzer J, et al. The diagnosis of cardiac arrhythmias: a prospective multi-center randomized study comparing mobile cardiac outpatient telemetry versus standard loop event monitoring. J Cardiovasc Electrophysiol. 2007 Mar;18(3):241-7. Resumo
68. Svennberg E, Tjong F, Goette A, et al. How to use digital devices to detect and manage arrhythmias: an EHRA practical guide. Europace. 2022 Jul 15;24(6):979-1005.Texto completo
69. Narasimha D, Hanna N, Beck H, et al. Validation of a smartphone-based event recorder for arrhythmia detection. Pacing Clin Electrophysiol. 2018 Mar 1 [Epub ahead of print]. Resumo
70. National Institute for Health and Care Excellence. Heart valve disease presenting in adults: investigation and management. Nov 2021 [internet publication].Texto completo
O uso deste conteúdo está sujeito ao nosso aviso legal